Key result
Metformin concentration-dependently inhibits LDL oxidation and reduces oxLDL cytotoxicity in endothelial cells.
Answers are grounded in this paper and cite their sources.
Demonstrates that metformin impedes copper-induced LDL oxidation and endothelial cytotoxicity in vitro, suggesting a protective role against atherosclerosis.
Metformin is the most commonly prescribed glucose-lowering drug for the treatment of type 2 diabetes. The aim of this study was to investigate whether metformin is capable of impeding the oxidation of LDL, a crucial step in the development of endothelial dysfunction and atherosclerosis. LDL was oxidized by addition of CuCl2 in the presence of increasing concentrations of metformin. The extent of LDL oxidation was assessed by measuring lipid hydroperoxide and malondialdehyde concentrations, relative electrophoretic mobilities, and oxidation-specific immune epitopes. Cytotoxicity of oxLDL in the vascular endothelial cell line EA.hy926 was assessed using the alamarBlue viability test. Quantum chemical calculations were performed to determine free energies of reactions between metformin and radicals typical for lipid oxidation. Metformin concentration-dependently impeded the formation of lipid hydroperoxides, malondialdehyde, and oxidation-specific immune epitopes when oxidation of LDL was initiated by addition of Cu2+. The cytotoxicity of oxLDL was reduced when it was obtained under increasing concentrations of metformin. The quantum chemical calculations revealed that only the reaction of metformin with hydroxyl radicals is exergonic, whereas the reactions with hydroperoxyl radicals or superoxide radical anions are endergonic. Metformin, beside its glucose-lowering effect, might be a suitable agent to impede the development of atherosclerosis and associated CVD. This is due to its capability to impede LDL oxidation, most likely by scavenging hydroxyl radicals.
No takes yet. Share an insight, caveat, or question.
Rossmann et al. (2023) studied Atherosclerosis and endothelial dysfunction (in vitro LDL oxidation model). Metformin vs. CuCl2-oxidized LDL without metformin was evaluated on Extent of LDL oxidation (lipid hydroperoxide, malondialdehyde, relative electrophoretic mobilities, oxidation-specific immune epitopes) and oxLDL cytotoxicity. Metformin concentration-dependently impeded Cu2+-induced LDL oxidation (lipid hydroperoxides, malondialdehyde, and immune epitopes) and reduced oxLDL cytotoxicity in EA.hy926 endothelial cells.
Synapse has enriched 10 related papers. Consider them for comparative context: